The insulin-like growth factor 1 (IGF-1) system was reported as a key regulator of the cancer growth pathway and it seems that the reduction of insulin levels through diet or medication (e.g. metformin) was beneficial in cancer patients (26). The gene discussed is IGF1; the disease is cancer.